Printable: IMF Patient and Family Seminar 2023

IMF Patient and Family Seminar 2023 — Boca Raton, FL (https://www.myeloma.org/videos/imf-patient-family-seminar-boca-raton)

Back in person for the first time since 2019, the International Myeloma Foundation (IMF) is excited to announce that the 2023 Boca Raton Patient and Family Seminar took place on March 17-18, 2023, in Boca Raton, Florida.

Meeting Slides

DOWNLOAD SLIDES (https://issuu.com/international-myeloma-foundation/docs/pfw-bocaraton-031723-slide_deck?fr=sOTg5YzU5MjAwMDg)

Video Replay

Patient Approaches to Relapse In Multiple Myeloma

This panel discussion is led by the IMF Chairman of the Board and Chief Scientific Officer, Dr. Brian G.M. Durie, and includes other distinguished myeloma experts, such as Dr. Nikhil Munshi, Dr. Peter Voorhees, and Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO.

The iStopMM (Iceland Screens Treats or Prevents Multiple Myeloma) Study

Dr. Kristinsson presents the history of the project and why the first large-scale screening study is so important.

Panel Discussion on the Groundbreaking Research iStopMM Study

Discover the groundbreaking research project iStopMM (Iceland Screens Treats or Prevents Multiple Myeloma) led by Dr. Sigurdur Kristinsson, Principal Investigator of the iStopMM study—a research Initiative, funded by the International Myeloma Foundation's Black Swan Research initiative.

First-Line or Frontline Therapy Options In Multiple Myeloma

Learn about "Frontline Therapy in Myeloma" presented by renowned multiple myeloma expert Dr. Peter Voorhees, recorded live at the 2023 International Myeloma Foundation Patient and Family Seminar in Boca Raton, Florida.

The Latest Insights on Immune Therapies in Myeloma

Experience the latest insights on "Immune Therapies in Myeloma" from world renowned multiple myeloma expert Dr. Nikhil Munshi, recorded live at the 2023 International Myeloma Foundation's Patient and Family Seminar in Boca Raton, Florida. Dr. Nikhil Munshi discusses the advances in immunotherapy for multiple myeloma, including vaccines, antibodies that directly kill myeloma cells, and antibodies that excite the immune system. He focuses on the most effective form of immunotherapy, passive immunotherapy, which involves modifying a patient's immune cells to kill myeloma cells. He discusses drugs that activate immune responses, as well as next-generation immunomodulators.

Author

Dr. Brian GM Durie (https://www.myeloma.org/Brian-Durie-md)

Header image Media

PFS_Event_Image.png

Series

Patient & Family Webinar (https://www.myeloma.org/taxonomy/term/26)

Meet Your Expert Speakers

Yelak Biru

IMF President and CEO, and 27-Year Myeloma Survivor

Brian G.M. Durie, MD

IMF Chief Scientific Officer and Chairman of the Board

James Hoffman,MD

Associate Professor of Clinical Medicine, Myeloma Division Sylvester Comprehensive Cancer Center, University of Miami — Miami, FL

IMF Chief Medical Officer Doctor Joseph Mikhael

Joseph Mikhael, MD

IMF Chief Medical Officer TGen, City of Hope — Phoenix, AZ

Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO

IMF Nurse Leadership Board Member Cleveland Clinic, Taussig Cancer Institute — Cleveland, OH

Sigurður Kristinsson, MD

PhD Principal Investigator of the IMF iStopMM Project University of Iceland — Reykjavik, Iceland

Peter Voorhees, MD

Professor of Medicine, Chief of the Plasma Cell Disorders Division Atrium Health, Levine Cancer Institute — Charlotte, NC

Nikhil Munshi, MD

Professor of Medicine, Harvard Medical School Associate Professor, Medical Oncology, Dana-Farber Cancer Institute Harvard Medical School and Dana-Farber Cancer Institute — Boston, MA